[Hyperfibrinolysis].
D062365:Aminobenzoates / Q000627:therapeutic use; D000614:Aminocaproates / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005342:Fibrinolysis
D062365:Aminobenzoates; D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D003509:Cyclohexanecarboxylic Acids; D007611:Aprotinin
Hyperfibrinolyse.